To further investigate the role of the FOXF2-CTSK axis in the interaction of breast cancer cells with bone, we performed bone-matrix invasion assays to test whether FOXF2-regulated CTSK secretion by cancer cells led to the degradation and invasion of the bone matrix. This evidence concerns the gene CTSK and cancer.